Trademark: 88716277
Word
INMAZEB
Status
Registered
Status Code
700
Status Date
Tuesday, September 28, 2021
Serial Number
88716277
Registration Number
6503050
Registration Date
Tuesday, September 28, 2021
Mark Type
4000
Filing Date
Thursday, December 5, 2019
Published for Opposition
Tuesday, March 24, 2020

Trademark Owner History
Regeneron Pharmaceuticals, Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations for treatment or prevention of Ebola virus infections; antivirals

Trademark Events
Jul 14, 2022
Teas Change Of Correspondence Received
Jul 14, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 14, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 28, 2021
Registered-Principal Register
Aug 26, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 25, 2021
Allowed Principal Register - Sou Accepted
Aug 13, 2021
Statement Of Use Processing Complete
Aug 4, 2021
Use Amendment Filed
Aug 13, 2021
Case Assigned To Intent To Use Paralegal
Aug 4, 2021
Teas Statement Of Use Received
Apr 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 14, 2021
Sou Extension 2 Granted
Apr 14, 2021
Sou Extension 2 Filed
Apr 14, 2021
Teas Extension Received
Oct 24, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 22, 2020
Sou Extension 1 Granted
Oct 22, 2020
Sou Extension 1 Filed
Oct 22, 2020
Teas Extension Received
May 19, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 24, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 24, 2020
Published For Opposition
Mar 4, 2020
Notification Of Notice Of Publication E-Mailed
Feb 20, 2020
Approved For Pub - Principal Register
Feb 20, 2020
Assigned To Examiner
Dec 11, 2019
New Application Office Supplied Data Entered In Tram
Dec 9, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24